First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial-Reference-Cited by-同舟云学术

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Published:2017-05 Issue:10083 Volume:389 Page:2031-2040
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Joly Pascal,Maho-Vaillant Maud,Prost-Squarcioni Catherine,Hebert Vivien,Houivet Estelle,Calbo Sébastien,Caillot Frédérique,Golinski Marie Laure,Labeille Bruno,Picard-Dahan Catherine,Paul Carle,Richard Marie-Aleth,Bouaziz Jean David,Duvert-Lehembre Sophie,Bernard Philippe,Caux Frederic,Alexandre Marina,Ingen-Housz-Oro Saskia,Vabres Pierre,Delaporte Emmanuel,Quereux Gaelle,Dupuy Alain,Debarbieux Sebastien,Avenel-Audran Martine,D'Incan Michel,Bedane Christophe,Bénéton Nathalie,Jullien Denis,Dupin Nicolas,Misery Laurent,Machet Laurent,Beylot-Barry Marie,Dereure Olivier,Sassolas Bruno,Vermeulin Thomas,Benichou Jacques,Musette Philippe

Funder

Programme Hospitalier de Recherche Clinique, French Ministry of Health

Publisher

Elsevier BV

Subject

General Medicine

Reference49 articles.

1. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion;Amagai;Cell,1991

2. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases;Stanley;J Clin Invest,1989

3. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease;Anhalt;N Engl J Med,1982

4. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome;Stanley;N Engl J Med,2006

5. Bullous pemphigoid and pemphigus vulgaris incidence and mortality in the UK: population based cohort study;Langan;BMJ,2008

Cited by 419 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center;Medicina;2024-02-04

2. Alterations in the innate and adaptive immune system in a real-world cohort of multiple sclerosis patients treated with ocrelizumab;Clinical Immunology;2024-02

3. Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy;JAMA Dermatology;2024-01-24

4. Restoring immune tolerance in pemphigus vulgaris;Proceedings of the National Academy of Sciences;2024-01-23

5. The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study;Journal of Dermatological Treatment;2024-01-22